Combination of enprostil and cimetidine is more effective than cimetidine alone in treating gastric ulcer: Prospective multicenter randomized controlled trial

Hepato-Gastroenterology

Volumn 52, Issue 66, 2005, Pages 1925-1929

  Murata, Hiroaki ^a   Kawano, Sunao ^b   Tsuji, Shingo ^a   Tsujii, Masahiko ^a   Hori, Masatsugu ^a   Kamada, Takenobu ^c   Matsuzawa, Yuuji ^d   Katsu, Kenichi ^e   Inoue, Kyouichi ^f   Kobayashi, Kenichi ^g   Mitsufuji, Syouji ^h   Bamba, Tadao ⁱ   Kawasaki, Hironaka ^j   Kajiyama, Goro ^k   Umegaki, Eiji ^e   Inoue, Masanori ^k   Saito, Ichimonji ^l  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA ROSAI HOSPITAL   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f KANSAI MEDICAL UNIVERSITY   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

^h KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

ⁱ Shiga Medical College   (Japan)

^j TOTTORI UNIVERSITY   (Japan)

^k HIROSHIMA UNIVERSITY   (Japan)

^l KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Cimetidine; Enprostil; Gastric ulcer; PGE 2 analogue; Prospective randomized trial

Indexed keywords

CIMETIDINE; ENPROSTIL; LACTATE DEHYDROGENASE;

ABDOMINAL DISCOMFORT; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADD ON THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRINKING BEHAVIOR; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; STOMACH ULCER; SYMPTOM; THROMBOCYTOPENIA; TREATMENT OUTCOME; ULCER HEALING;

ADULT; AGED; CIMETIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENPROSTIL; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; JAPAN; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STOMACH ULCER; TREATMENT OUTCOME;

EID: 28544445688     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peterson WL: Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324:1043-1048.
2. Murata H, et al: Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: Prospective randomized multicenter study. J Gastroenterol Hepatol 2003; 18:1029-1033.
3. Nebiki H, et al: Quality of ulcer healing influences the relapse of gastric ulcer in humans. J Gastroenterol Hepatol 1997; 12:109-114.
4. Graham DY, et al: Prevention of NSAID-induced gastric ulcer with misoprostol; multicenter, double-blind, placebo-controlled trial. Lancet 1988; 2:1277-1280.
5. Roszkowski AP, et al: Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17, 18, 19, 20-tetranor-9-oxoprosta-4, 5, 13 (t)-trienoic acid methyl ester. J Pharmacol Exp Ther 1986; 239:382-389.
6. Dammann HG, et al: Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer. Am J Med 1986; 81:80-84.
7. Morgan AG, et al: A comparison between enprostil and ranitidine in the management of gastric ulceration. Aliment Pharmacol Ther 1990; 4:635-641.
8. Bardhan KD, et al: Gastric ulcer healing: a comparison of enprostil versus ranitidine. J Clin Gastroenterol 1991; 13:157-162.
9. Cohen MM, et al. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study. Gastroenterology 1985; 88:382-386.
10. Shorrock CJ, et al: Effect of enprostil on amphibian gastroduodenal and human gastric bicarbonate secretion. Dig Dis Sci 1989; 34:1016-1020.
11. Waterbury LD, et al: Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion. Am J Med 1986; 81:30-33.
12. 2 on 24 hour intragastric acidity, nocturnal acid and pepsin secretion. Gut 1986; 27:1054-1057.
13. 2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. Am J Med 1986; 81:44-49.
14. Meijer JL, et al: Effect of enprostil on serum gastrin and pepsinogen A and C levels in patients on long-term treatment with omeprazole. Aliment Pharmacol Ther 1994; 8:221-227.
15. Hausken T, et al: Antroduodenal motility studied by real-time ultrasonography. Effect of enprostil. Gastroenterology 1991; 100:59-63.
16. O'Brien P, et al: Protective effects of the synthetic prostaglandin enprostil on the gastric microvasculature after ethanol injury in the rat. Am J Med 1986; 81:12-17.
17. Walan A, et al: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320:69-75.
18. Kawano S, et al: Age-related change in human gastric mucosal energy metabolism. Scand J Gastroenterol 1991; 26:701-706.
19. Kishimoto M, et al: Characteristics of gastric mucus in elderly patients with gastric ulcers. Hepatogastroenterology 2001; 48:1594-1598.
20. Chow JY, et al: The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats. Gastroenterology 1997; 113:1188-1197.
21. Okada M, et al: Factors influencing the healing rate of gastric ulcer in hospitalized subjects. Gut 1984; 25:881-885.
22. Kawano S, et al: Effect of cigarette smoking on the gastric mucosal blood volume index and hemoglobin oxygenation in man. Gastroenterol Jpn 1989; 24:1-7.
23. Masuda E, et al: Effect of intravascular ethanol on modulation of gastric mucosal integrity: possible role of endothelin-1. Am J Physiol 1992; 262:G785-790.
24. Giannarelli S, et al: Effect of enprostil and cimetidine on ethanol-induced damage to intestinal epithelial cell lines IRD 98 and IEC 17. Digestion 1995; 56:509-515.